CA2103665A1 - Agents antiretroviraux oligopeptidiques - Google Patents

Agents antiretroviraux oligopeptidiques

Info

Publication number
CA2103665A1
CA2103665A1 CA002103665A CA2103665A CA2103665A1 CA 2103665 A1 CA2103665 A1 CA 2103665A1 CA 002103665 A CA002103665 A CA 002103665A CA 2103665 A CA2103665 A CA 2103665A CA 2103665 A1 CA2103665 A1 CA 2103665A1
Authority
CA
Canada
Prior art keywords
oligopeptide
moiety
antiretroviral agents
antiretroviral
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002103665A
Other languages
English (en)
Other versions
CA2103665C (fr
Inventor
J. William Lown
Ronald George Micetich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Alberta
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2103665A1 publication Critical patent/CA2103665A1/fr
Application granted granted Critical
Publication of CA2103665C publication Critical patent/CA2103665C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002103665A 1991-02-06 1992-02-05 Agents antiretroviraux oligopeptidiques Expired - Fee Related CA2103665C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65061691A 1991-02-06 1991-02-06
US650,616 1991-02-06
PCT/CA1992/000051 WO1992013838A1 (fr) 1991-02-06 1992-02-05 Agents antiretroviraux oligopeptidiques

Publications (2)

Publication Number Publication Date
CA2103665A1 true CA2103665A1 (fr) 1992-08-07
CA2103665C CA2103665C (fr) 2003-04-15

Family

ID=24609608

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002103665A Expired - Fee Related CA2103665C (fr) 1991-02-06 1992-02-05 Agents antiretroviraux oligopeptidiques

Country Status (4)

Country Link
AU (1) AU1224392A (fr)
CA (1) CA2103665C (fr)
WO (1) WO1992013838A1 (fr)
ZA (1) ZA92864B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9216962D0 (en) * 1992-08-11 1992-09-23 Erba Carlo Spa Therapeutically active naphthalenesulfonic-pyrrolecarboxamido derivatives
GB9307948D0 (en) * 1993-04-16 1993-06-02 Erba Carlo Spa Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease
AU7380294A (en) * 1993-08-06 1995-02-28 Synphar Laboratories, Inc. Oligopeptide antiretroviral agents
US6635417B1 (en) 1996-07-31 2003-10-21 California Institute Of Technology Complex formation between DSDNA and oligomer of cyclic heterocycles
US6090947A (en) * 1996-02-26 2000-07-18 California Institute Of Technology Method for the synthesis of pyrrole and imidazole carboxamides on a solid support
US6555692B1 (en) 1996-02-26 2003-04-29 California Institute Of Technology Preparation and use of bifunctional molecules having DNA sequence binding specificity
AU6757698A (en) 1996-02-26 1998-10-30 California Institute Of Technology Stereochemical control of the dna binding affinity, sequence specificity, and orientation-preference of chiral hairpin polyamides in the minor groove
US6143901A (en) * 1996-07-31 2000-11-07 Genesoft, Inc. Complex formation between dsDNA and pyrrole imidazole polyamides
WO1998037066A1 (fr) 1996-02-26 1998-08-27 California Institute Of Technology Polyamides ameliores pour assurer une liaison dans le sillon mineur de l'adn a double brins
US6506906B1 (en) 1996-02-26 2003-01-14 California Institute Of Technology Preparation and use of bifunctional molecules having DNA sequence binding specificity
US5998140A (en) * 1996-07-31 1999-12-07 The Scripps Research Institute Complex formation between dsDNA and oligomer of cyclic heterocycles
KR20030043785A (ko) 2000-03-16 2003-06-02 젠소프트, 인크. 핵산 결합 부위를 포함하는 하전된 화합물 및 이의 용도
US7078536B2 (en) 2001-03-14 2006-07-18 Genesoft Pharmaceuticals, Inc. Charged compounds comprising a nucleic acid binding moiety and uses therefor
US7122626B2 (en) 2001-04-26 2006-10-17 Genesoft Pharmceuticals, Inc. Halogen-substitued thienyl compounds
AU2003258022A1 (en) 2002-08-02 2004-02-23 Genesoft Pharmaceuticals, Inc. Biaryl compounds having anti-infective activity
WO2004039318A2 (fr) 2002-10-25 2004-05-13 Genesoft Pharmaceuticals, Inc. Composes biaryle anti-infectieux
CA2508769A1 (fr) 2002-12-10 2004-06-24 Oscient Pharmaceuticals Corporation Composes antibacteriens possedant un motif (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide)
DE102004055582A1 (de) * 2004-11-18 2006-05-24 Bayer Cropscience Ag N-Heterocyclyl-phthalsäurediamide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665184A (en) * 1983-10-12 1987-05-12 California Institute Of Technology Bifunctional molecules having a DNA intercalator or DNA groove binder linked to ethylene diamine tetraacetic acid
CN85103908A (zh) * 1985-07-16 1986-11-05 法米塔利·卡洛·埃尔巴有限公司 制备4′-表多克索红菌素的新方法
AT387013B (de) * 1985-07-16 1988-11-25 Erba Farmitalia Verfahren zur herstellung von poly-4-aminopyrrol -2-carboxamidoderivaten
CA1308516C (fr) * 1987-07-06 1992-10-06 The Governors Of The University Of Alberta Agents antiviraux et anticancereux oligopeptidiques
GB9000644D0 (en) * 1990-01-11 1990-03-14 Erba Carlo Spa New ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds

Also Published As

Publication number Publication date
ZA92864B (en) 1993-01-27
CA2103665C (fr) 2003-04-15
AU1224392A (en) 1992-09-07
WO1992013838A1 (fr) 1992-08-20

Similar Documents

Publication Publication Date Title
CA2043976A1 (fr) Derives de substitution de phtalides et phtalides heterocycliques
CA2395558A1 (fr) Imidazotriazinones a substitution 2-phenyle utilisees comme inhibiteurs des phosphodiesterases
CA2037408A1 (fr) Solution macrolide pharmaceutique non-aqueuse
RU93049322A (ru) Производные оксадиазинов
CA2131683A1 (fr) Derives de stilbene et compositions pharmaceutiques en contenant
CA2192289A1 (fr) Derives de substitution heterocycliques
CA2064382A1 (fr) Composes pharmaceutiques
CA2064636A1 (fr) Sulfonylaminocarbonyltriazolinones renfermant des groupes de substitution lies par l'intermediaire de l'oxygene
DE60310532D1 (de) Bestimmung von nukleinsäuren
CA2115536A1 (fr) Derives heterocycliquement substitues de phenyl-cyclohexane-acide carboxylique
WO1995004732B1 (fr) Agents antiretroviraux oligopeptidiques
CA2114300A1 (fr) Derives de la quinoline ou de la quinazoline, leur production et utilisation
CA2040517A1 (fr) Derives de 1,8-naphtyridin-2-one
CA2098495A1 (fr) Derives 1,4-benzothiazepine
CA2050255A1 (fr) Derives du 1-methylcarbapenem et procede d'obtention
CA2327635A1 (fr) Composes d'uracile et utilisation de ces composes
CA2001205A1 (fr) Quinolonyl lactams antimicrobiens
CA2002834A1 (fr) Xanthines cycloalkyles
CA2078811A1 (fr) Sulfonylaminocarbonyltriazolinones renfermant deux substituants lies par l'oxygene
EP1070711A3 (fr) Dérivés de pyrrole hétéroaryl substitués, leur préparation et leur utilisation thérapeutique
CA2013518A1 (fr) Derives de thieno-triazolo-diazepine, procede de preparation et composes therapeutiques les contenant
CA2241092A1 (fr) Derives de 1-methylcarbapenem
CA2039039A1 (fr) Derive de nucleoside pyrimidique et agent antiviral contenant le derive en tant qu'ingredient actif
CA2114301A1 (fr) Composition herbicide de faible phytotoxicite
CA2078871A1 (fr) Derives de squalene cyclopropylique et leur utilisation en tant qu'inhibiteurs de la synthese du cholesterol

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed